m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00352)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
NR2E1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | GSEA revealed that KIAA1429, METTL3, and IGF2BP1 were significantly related to multiple biological behaviors, including proliferation, apoptosis, metastasis, energy metabolism, drug resistance, and recurrence, and that KIAA1429 and IGF2BP1 had potential target genes, including E2F3, WTAP, CCND1, CDK4, EGR2, YBX1, and Nuclear receptor subfamily 2 group E member 1 (TLX/NR2E1), which were associated with lung cancers. | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Cell Process | Cell apoptosis | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
NCI-H520 | Lung squamous cell carcinoma | Homo sapiens | CVCL_1566 | |
HBE (Human bronchial epithelial cell line) | ||||
LTEP-a2 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6929 | |
SK-MES-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0630 | |
Protein virilizer homolog (VIRMA) [WRITER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | GSEA revealed that KIAA1429, METTL3, and IGF2BP1 were significantly related to multiple biological behaviors, including proliferation, apoptosis, metastasis, energy metabolism, drug resistance, and recurrence, and that KIAA1429 and IGF2BP1 had potential target genes, including E2F3, WTAP, CCND1, CDK4, EGR2, YBX1, and Nuclear receptor subfamily 2 group E member 1 (TLX/NR2E1), which were associated with lung cancers. | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Cell Process | Cell apoptosis | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
NCI-H520 | Lung squamous cell carcinoma | Homo sapiens | CVCL_1566 | |
HBE (Human bronchial epithelial cell line) | ||||
LTEP-a2 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6929 | |
SK-MES-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0630 | |
Lung cancer [ICD-11: 2C25]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | GSEA revealed that KIAA1429, METTL3, and IGF2BP1 were significantly related to multiple biological behaviors, including proliferation, apoptosis, metastasis, energy metabolism, drug resistance, and recurrence, and that KIAA1429 and IGF2BP1 had potential target genes, including E2F3, WTAP, CCND1, CDK4, EGR2, YBX1, and Nuclear receptor subfamily 2 group E member 1 (TLX/NR2E1), which were associated with lung cancers. | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | ||
Cell Process | Cell apoptosis | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
NCI-H520 | Lung squamous cell carcinoma | Homo sapiens | CVCL_1566 | |
HBE (Human bronchial epithelial cell line) | ||||
LTEP-a2 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6929 | |
SK-MES-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0630 | |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | GSEA revealed that KIAA1429, METTL3, and IGF2BP1 were significantly related to multiple biological behaviors, including proliferation, apoptosis, metastasis, energy metabolism, drug resistance, and recurrence, and that KIAA1429 and IGF2BP1 had potential target genes, including E2F3, WTAP, CCND1, CDK4, EGR2, YBX1, and Nuclear receptor subfamily 2 group E member 1 (TLX/NR2E1), which were associated with lung cancers. | |||
Responsed Disease | Lung cancer [ICD-11: 2C25] | |||
Target Regulator | Protein virilizer homolog (VIRMA) | WRITER | ||
Cell Process | Cell apoptosis | |||
In-vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens | CVCL_0023 |
NCI-H520 | Lung squamous cell carcinoma | Homo sapiens | CVCL_1566 | |
HBE (Human bronchial epithelial cell line) | ||||
LTEP-a2 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6929 | |
SK-MES-1 | Lung squamous cell carcinoma | Homo sapiens | CVCL_0630 | |